drugset / Trial / NCT04296149

Beta- Probe and Surgery in GEP NET: Evaluation of a New Probe

NCT04296149

Phase 2 Completed 5 enrolled European Institute of Oncology
NaSingle-groupOpen-labelDiagnostic

Summary

Radioguided surgery (RGS) with beta- radioisotopes is a novel approach focused on developing a new probe which, detecting electrons and operating with low background, provides a clearer delineation of the margins of lesions with low radiation exposition for surgeons. To validate this procedure, ex vivo specimens of tumours expressing somatostatin receptors, as small-intestine neuroendocrine (SI-NET), will be tested

Timeline

Start
2017-02-16
Primary completion
2018-12-31
Completion
2019-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject 90Y-DOTATOC Peptide